Abstract
Intra-carotid cold infusion (ICCI) appears as a promising method for hypothermia-mediated brain protection from ischemic stroke. Recent clinical pilot studies indicate easy implementation of ICCI into endovascular acute ischemic stroke treatment. Current rodent ICCI-in-stroke models limit ICCI to the post-reperfusion phase. To establish a method for continuous ICCI over the duration of intra-ischemia to post-reperfusion in rodent stroke models, a novel system was developed. Eighteen male Sprague-Dawley rats were included. Intraluminal filament method was used for transient middle cerebral artery occlusion (MCAO). Normal saline (~ 0 °C) was delivered (≤ 2.0 mL/min) into the internal carotid artery via a customized infusion system without interruption during MCAO (intra-ischemia) to after filament withdrawal (post-reperfusion). Bilateral cortical and striatal temperatures were monitored. Hypothermia goals were a temperature reduction in the ischemic hemisphere by 2 °C prior to reperfusion and thereafter maintenance of regional brain hypothermia at ~ 32 °C limiting the administered ICCI volume to ½ of each rat’s total blood volume. During ischemia, maximum brain cooling rate was achieved with ICCI at 0.5 mL/min. It took 2 min to reduce ischemic striatal temperature by 2.3 ± 0.3 °C. After reperfusion, brain cooling was continued at 2 mL/min ICCI first (over 42 s) and maintained at 32.1 ± 0.3 °C at 0.7 mL/min ICCI over a duration of 15 ± 0.8 min. ICCI (total 12.6 ± 0.6 mL) was uninterrupted over the duration of the studied phases. First system that allows continuous ICCI during the phases of intra-ischemia to post-reperfusion in small animals for selective brain cooling and for investigations of other neuroprotective infusions.
Highlights
IntroductionDespite strong pre-clinical results indicating the potential of therapeutic hypothermia to protect the brain in acute ischemic
Despite strong pre-clinical results indicating the potential of therapeutic hypothermia to protect the brain in acute ischemicStroke Program, Cumming School of Medicine, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada stroke [1, 2], clinical trials so far have failed to show a beneficial effect
As an alternative to whole-body hypothermia, selective brain cooling via cold infusion into brain-supplying arteries offers several advantages that could improve the likelihood of success to translate hypothermia-mediated neuroprotection from experimental studies into clinical ischemic stroke: First, by hijacking the cerebral circulation instead of fighting against the inflow of warm arterial blood into the brain, and targeting only the organ or tissue of interest, i.e., the ischemic hemisphere, this infusion method enables ultra-rapid induction of “focused” hypothermia [5]
Summary
Despite strong pre-clinical results indicating the potential of therapeutic hypothermia to protect the brain in acute ischemic. Recent randomized controlled trials in stroke patients have struggled with feasibility and issues regarding the safety of whole-body hypothermia, the current standard of therapeutic hypothermia [3, 4]. As an alternative to whole-body hypothermia, selective brain cooling via cold infusion into brain-supplying arteries offers several advantages that could improve the likelihood of success to translate hypothermia-mediated neuroprotection from experimental studies into clinical ischemic stroke: First, by hijacking the cerebral circulation instead of fighting against the inflow of warm arterial blood into the brain, and targeting only the organ or tissue of interest, i.e., the ischemic hemisphere, this infusion method enables ultra-rapid induction of “focused” hypothermia [5].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.